Cargando…

Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease

Prevalence of sarcopenia is high in patients with chronic kidney disease (CKD), especially in those with dialysis. Various pathological conditions related to CKD, such as chronic inflammation, insulin resistance, and endothelial dysfunction, are thought to be associated with the development and prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yabuuchi, Junko, Ueda, Seiji, Yamagishi, Sho-ichi, Nohara, Nao, Nagasawa, Hajime, Wakabayashi, Keiichi, Matsui, Takanori, Yuichiro, Higashimoto, Kadoguchi, Tomoyasu, Otsuka, Tomoyuki, Gohda, Tomohito, Suzuki, Yusuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573579/ https://www.ncbi.nlm.nih.gov/pubmed/33077879 http://dx.doi.org/10.1038/s41598-020-74673-x

Ejemplares similares

Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor
por: Ishibashi, Yuji, et al.
Publicado: (2013)

DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice
por: Sotokawauchi, Ami, et al.
Publicado: (2021)

N-butanol extracts of Morinda citrifolia suppress advanced glycation end products (AGE)-induced inflammatory reactions in endothelial cells through its anti-oxidative properties
por: Ishibashi, Yuji, et al.
Publicado: (2017)

Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE
por: Matsui, Takanori, et al.
Publicado: (2015)

Advanced glycation end products, oxidative stress and diabetic nephropathy
por: Yamagishi, Sho-ichi, et al.
Publicado: (2010)

DNA-Aptamer Raised against Receptor for Advanced Glycation End Products Improves Survival Rate in Septic Mice
por: Koga, Yoshinori, et al.
Publicado: (2021)

Role of receptor for advanced glycation end products (RAGE) in liver disease
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Glyceraldehyde-Derived Pyridinium Evokes Renal Tubular Cell Damage via RAGE Interaction
por: Sotokawauchi, Ami, et al.
Publicado: (2020)

Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis
por: Yamagishi, Sho-ichi, et al.
Publicado: (2018)

Long-Term Local Injection of RAGE-Aptamer Suppresses the Growth of Malignant Melanoma in Nude Mice
por: Nakamura, Nobutaka, et al.
Publicado: (2019)

Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression
por: Ishibashi, Yuji, et al.
Publicado: (2014)

SMTP-44D Inhibits Atherosclerotic Plaque Formation in Apolipoprotein-E Null Mice Partly by Suppressing the AGEs-RAGE Axis †
por: Terasaki, Michishige, et al.
Publicado: (2023)

Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Aqueous Extract of Glucoraphanin-Rich Broccoli Sprouts Inhibits Formation of Advanced Glycation End Products and Attenuates Inflammatory Reactions in Endothelial Cells
por: Sotokawauchi, Ami, et al.
Publicado: (2018)

Predictive ability of serum advanced glycation end products at 11 to 13 weeks of gestation for early-onset preeclampsia
por: Goto, Minako, et al.
Publicado: (2022)

DNA Aptamer Raised Against AGEs Blocks the Progression of Experimental Diabetic Nephropathy
por: Kaida, Yusuke, et al.
Publicado: (2013)

Continuous extracorporeal treatments in a dialysis patient with COVID-19
por: Nihei, Yoshihito, et al.
Publicado: (2020)

Pathological Role of Receptor for Advanced Glycation End Products in Calcified Aortic Valve Stenosis
por: Saku, Kosuke, et al.
Publicado: (2020)

Sarcopenia and Frailty in Liver Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

The Role of Sirtuins in Sarcopenia and Frailty
por: Anwar, Masroor, et al.
Publicado: (2023)

Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinic
por: Tamura, Yoshiaki, et al.
Publicado: (2018)

Osteosarcopenia, the co-existence of osteoporosis and sarcopenia, is associated with social frailty in older adults
por: Inoue, Tatsuro, et al.
Publicado: (2021)

Oral Management in Rehabilitation Medicine: Oral Frailty, Oral Sarcopenia, and Hospital-Associated Oral Problems
por: Shiraishi, A., et al.
Publicado: (2020)

Diabetes related fatigue sarcopenia, frailty
por: Lien, Angela Shin‐Yu, et al.
Publicado: (2017)

Sarcopenia, Frailty, and Diabetes in Older Adults
por: Jang, Hak Chul
Publicado: (2016)

The frailty phenotype and sarcopenia: Similar but not the same
por: Cesari, Matteo
Publicado: (2019)

Mitochondria: between aging, frailty and sarcopenia
por: Davin, Annalisa, et al.
Publicado: (2023)

RAGE-aptamer attenuates deoxycorticosterone acetate/salt-induced renal injury in mice
por: Taguchi, Kensei, et al.
Publicado: (2018)

Hospital‐associated sarcopenia, acute sarcopenia, and iatrogenic sarcopenia: Prevention of sarcopenia during hospitalization
por: Wakabayashi, Hidetaka
Publicado: (2023)

COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine
por: Fukao, Yusuke, et al.
Publicado: (2021)

Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force
por: Cesari, Matteo, et al.
Publicado: (2022)

Cancer Malignancy Is Enhanced by Glyceraldehyde-Derived Advanced Glycation End-Products
por: Takino, Jun-Ichi, et al.
Publicado: (2010)

Undernutrition, Sarcopenia, and Frailty in Fragility Hip Fracture: Advanced Strategies for Improving Clinical Outcomes
por: Inoue, Tatsuro, et al.
Publicado: (2020)

Osteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly
por: Greco, Emanuela A., et al.
Publicado: (2019)

Sarcopenia and Frailty: Challenges in Mainstream Nephrology Practice
por: Wong, Limy, et al.
Publicado: (2021)

Frailty and Sarcopenia in Acute‐on‐Chronic Liver Failure
por: Puchades Renau, Lorena, et al.
Publicado: (2021)

Editorial: Sarcopenia, Frailty and Nutrition in Liver Diseases
por: Iacob, Speranta, et al.
Publicado: (2022)

Healthcare cost expenditures associated to frailty and sarcopenia
por: Álvarez-Bustos, Alejandro, et al.
Publicado: (2022)

Innovation in Digital Health Interventions for Frailty and Sarcopenia
por: Kato, Yuki, et al.
Publicado: (2023)

From sarcopenia to frailty: a road less traveled
por: Morley, John E., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kmf5nlfoml1jlu0mjvdhmitb1t